News | Breast Imaging | March 28, 2016

Frost & Sullivan Recognizes Volpara Solutions Quantitative Breast Imaging Tools

Company cites Volpara’s enhanced quantitative analytics capabilities as major growth drivers in breast density assessment market

Frost & Sullivan, Volpara Solutions, 2016 award, breast density

March 28, 2016 — Based on its recent analysis of the breast density assessment solutions market, Frost & Sullivan recognizes Volpara Solutions with the 2016 Global Frost & Sullivan Award for Competitive Strategy Innovation and Leadership.

Volpara Solutions offers a suite of multi-vendor breast imaging tools including VolparaDensity, VolparaAnalytics, VolparaDose, and VolparaResearch. The quantitative software tools allow for personalized measurements of volumetric breast density, patient dose, breast compression and other factors designed to help maintain accuracy and consistent quality in breast screening.

VolparaAnalytics provides quality metrics and key performance indicators that let facilities evaluate their mammography and tomosynthesis system utilization, examination times, patient dose, patient positioning and patient comfort. This can help sites correct issues that may impact the quality of the breast imaging services they deliver and help improve quality of care.

"The company believes that the more specific data it provides to the medical professional, the more it contributes to securing an accurate diagnosis for patients, and this is a driving force behind new solution developments that collect a new type of data," said Frost & Sullivan's Research Associate, Svetlana Korosteleva. "Volpara Solutions leverages modern network technologies and supporting IT [information technology] deployment models. It intends to further expand its analytics capabilities by leveraging wider sets of metrics that enable it to switch to predictive healthcare, the next frontier for the healthcare industry."

Frost & Sullivan is pleased to recognize Volpara Solutions for innovative strategies in strengthening its brand and thereby, demand for its products, in the intensely competitive breast density assessment solutions market.

Each year, Frost & Sullivan presents this award to the company that has leveraged competitive intelligence to successfully execute a competitive strategy that results in stronger market share, competitive brand positioning and customer satisfaction.

For more information:

Related Content

SmartCurve technology, a revolutionary breast imaging technology designed specifically for the curvature of the female breast to provide every woman with a more comfortable and accurate mammogram.
News | Mammography | September 14, 2018
Solis Mammography declared September Breast Wellness Month a
breast screening
News | Clinical Trials | September 13, 2018
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the a
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin
If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club.
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...